181
Treatment with growth hormone from dead people combined with a fairly young age of development of the disease allowed scientists to conclude that Alzheimer’s disease in patients was not sporadic or hereditary in nature. They believe that its development is due to the transmission of a pathogenic form of beta-amyloid. At the same time, there is no risk of new cases of transmission of the disease in this way today due to the fact that therapy with growth hormone of cadaveric origin is no longer practised.